ZA857945B - 4-hydroxy-3-quinoline carboxylic acid derivatives substituted at position 2 by an alpha-hydroxylated chain,process for their preparation,their use as medicaments and compositions containing them - Google Patents

4-hydroxy-3-quinoline carboxylic acid derivatives substituted at position 2 by an alpha-hydroxylated chain,process for their preparation,their use as medicaments and compositions containing them

Info

Publication number
ZA857945B
ZA857945B ZA857945A ZA857945A ZA857945B ZA 857945 B ZA857945 B ZA 857945B ZA 857945 A ZA857945 A ZA 857945A ZA 857945 A ZA857945 A ZA 857945A ZA 857945 B ZA857945 B ZA 857945B
Authority
ZA
South Africa
Prior art keywords
carbon atoms
alkyl
group
hydrogen
hydroxy
Prior art date
Application number
ZA857945A
Other languages
English (en)
Inventor
Francois Clemence
Odile Le Martret
Francoise Delevallee
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ZA857945B publication Critical patent/ZA857945B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ZA857945A 1984-10-30 1985-10-16 4-hydroxy-3-quinoline carboxylic acid derivatives substituted at position 2 by an alpha-hydroxylated chain,process for their preparation,their use as medicaments and compositions containing them ZA857945B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8416573A FR2572404B2 (fr) 1984-10-30 1984-10-30 Nouveaux derives de l'acide 4-oh-3-quinoleine carboxylique substitues en 2, leur procede de preparation, leur application comme medicaments et les compositions les renfermant

Publications (1)

Publication Number Publication Date
ZA857945B true ZA857945B (en) 1986-12-30

Family

ID=9309131

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA857945A ZA857945B (en) 1984-10-30 1985-10-16 4-hydroxy-3-quinoline carboxylic acid derivatives substituted at position 2 by an alpha-hydroxylated chain,process for their preparation,their use as medicaments and compositions containing them

Country Status (14)

Country Link
US (1) US4735951A (ko)
EP (1) EP0183584B1 (ko)
JP (1) JPH0788379B2 (ko)
KR (1) KR920008822B1 (ko)
AT (1) ATE48424T1 (ko)
AU (1) AU601942B2 (ko)
CA (1) CA1259072A (ko)
DE (1) DE3574592D1 (ko)
ES (2) ES8702360A1 (ko)
FR (1) FR2572404B2 (ko)
GR (1) GR852568B (ko)
HU (1) HU197327B (ko)
PT (1) PT81391B (ko)
ZA (1) ZA857945B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845105A (en) * 1984-10-30 1989-07-04 Roussel Uclaf 4-OH-quinoline carboxylic acid amides having analgesic and anti-inflammatory activity
JPH02237443A (ja) * 1989-03-07 1990-09-20 Matsushita Electric Ind Co Ltd コアレスモータの回転子
AU8612491A (en) * 1990-09-07 1992-03-30 Schering Corporation Antiviral compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530633A1 (fr) * 1982-06-03 1984-01-27 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, et les compositions les renfermant
FR2566405B1 (fr) * 1984-06-25 1986-09-26 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus

Also Published As

Publication number Publication date
DE3574592D1 (de) 1990-01-11
ES8702360A1 (es) 1987-01-01
ES548300A0 (es) 1987-01-01
JPH0788379B2 (ja) 1995-09-27
ATE48424T1 (de) 1989-12-15
HUT40649A (en) 1987-01-28
PT81391A (fr) 1985-11-01
AU601942B2 (en) 1990-09-27
PT81391B (pt) 1988-02-17
EP0183584A1 (fr) 1986-06-04
HU197327B (en) 1989-03-28
JPS61109770A (ja) 1986-05-28
KR860003250A (ko) 1986-05-21
EP0183584B1 (fr) 1989-12-06
KR920008822B1 (ko) 1992-10-09
FR2572404A2 (fr) 1986-05-02
AU4917385A (en) 1986-05-08
ES556096A0 (es) 1987-11-01
FR2572404B2 (fr) 1987-12-11
ES8800162A1 (es) 1987-11-01
US4735951A (en) 1988-04-05
GR852568B (ko) 1986-02-21
CA1259072A (fr) 1989-09-05

Similar Documents

Publication Publication Date Title
SE7700804L (sv) Sett att framstella nya 3-kinolinkarboxylsyraderivat
ES8103045A1 (es) Procedimiento para preparar nuevos derivados del acido 3- quinoleincarboxilico
ZA889023B (en) 2-(piperazinyl)-2-oxoethylene substituted flavonoid derivatives,processes for preparing them and pharmaceutical compositions containing them
SE8302474D0 (sv) Nya derivat av 4-hydroxi-3-kinolein-karboxylsyraderivat, substituerade i 2-stellning framstellning derav, anvendning derav som lekemedel samt kompositioner innehallande dem samt erhallna mellanprodukter
IL61687A (en) (benzothiazole-2-yl-thio)-phenylpropionic acid derivatives,pharmaceutical formulations containing them and a process for their preparation
ZA857945B (en) 4-hydroxy-3-quinoline carboxylic acid derivatives substituted at position 2 by an alpha-hydroxylated chain,process for their preparation,their use as medicaments and compositions containing them
EP0169755A3 (en) 4-hydroxy-3-quinoline-carboxylic-acid derivatives substituted at 2 by a nitrogen-containing group, their preparation, their use as medicaments, compositions containing them and intermediates
DE3069173D1 (en) Substituted phenylamino-2-imidazoline-2 derivatives, their acid addition salts, medicaments containing them and process for their preparation
HU894471D0 (en) Process for the preparation of 15-amino-20,21-dinor-eburnamenine derivatives and pharmaceutical compositions containing them
ATE64383T1 (de) 8-phenylthiotetrahydrochinolin-derivate und ihre salze, ihre herstellung, verwendung als arzneimittel und zusammensetzungen davon.
IL70272A (en) Acridanone(2-thiazolyl)-hydrazone derivatives,their manufacture and pharmaceutical compositions containing them
FI844131A0 (fi) Menetelmä 2-substituoitujen 3-kinoliinikarboksamidien valmistuksessa välituotteina käytettävien 2-asyyliamino- -oksobentseenipropaaniamidien valmistamiseksi